VIVORYON THERAPEUTICS N.V. EUR0.01 financial statements, including revenue, expenses, profit, and loss

The total revenue of 0R3M for the last semiannual is 0.00 EUR, and it's 100.00% higher compared to the previous semiannual. The net income of H1 24 is -13.56 M EUR.